Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
23,042,098
-
Shares change
-
+4,075,802
-
Total reported value, excl. options
-
$171,205,266
-
Value change
-
+$31,378,307
-
Put/Call ratio
-
36%
-
Number of buys
-
39
-
Number of sells
-
37
-
Price
-
$7.43
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2024
As of 31 Dec 2024 LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,042,098 shares of stock of the company.
Largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., and DCF Advisers, LLC.
This table shows 96 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.